The study demonstrates significant variability in poliovirus antibody content among human gamma-globulin preparations, highlighting the need for careful standardization.
Answers are grounded in this paper and cite their sources.
Variability in gamma-globulin potency requires standardization; animal data leaves open clinical translation and optimal sourcing.
Summary Poliovirus antibody content of 275 samples of human γ-globulin have been determined in Rhesus kidney or in HEp-2 cell cultures by the metabolic inhibition test, in comparison with a reference globulin preparation. Globulins prepared from placental extracts showed, on the average, higher antibody content for each of the three types of poliovirus than globulins prepared from venous blood. The potencies of the globulin preparations varied up to 100-fold, indicating the need for careful standardization of each lot and establishment of minimum potency levels. The technique for the potency test is described.
No takes yet. Share an insight, caveat, or question.
Uhlendorf et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: